Harrison Tam, PhD
**** ******* ***. **, ******* MN 55432
763-***-**** / acvxoo@r.postjobfree.com
PhD level clinical and laboratory scientist seeking a career in clinical research
Summary
* ***** ** *aboratory and clinical research experience in various fields including brain cancer, obesity, cardiovascular disease, and drug metabolism.
Demonstrated leadership and teaching experience at all stages of career from undergraduate to post doctoral scholar
Passion for helping people by discovering breakthroughs that help save lives
Work and Research Experience
Post-Doctoral Scholar February 2015-February 2016
University of Kentucky, College of Pharmacy
Project: Regulation of P-gp and BCRP to Improve Efficacy of Chemotherapeutics for Treatment of Brain Cancer
Supervisor: Dr. Bjoern Bauer
Established a cell-culture lab and a cell-culture based model of brain cancer in mice
Developed IACUC and IRB protocols for an in-vivo imaging system to quantitate cancer growth in mice
Isolated brain capillaries of mice and rats for use as an ex-vivo model of the blood-brain barrier and to measure transport function
Research Assistant September 2010 –February 2015
University of Minnesota, College of Pharmacy
Project: The Effect of Obesity on Drug Clearance and Cardiovascular Disease Risk Factors
Supervisor: Dr. L’Aurelle Johnson
Developed and implemented pre-clinical and clinical protocols for assessing changes in drug pharmacokinetics in obesity
Assessed expression and activity levels of xenobiotic metabolizing enzymes in animal models of obesity
Designed and optimized analytical assays for measuring UGT substrates and their metabolites using mass spectrometry, high performance liquid chromatography, and gas chromatography
Teaching Assistant January 2011-May 2014
University of Minnesota, College of Pharmacy
Facilitated teaching support (such as developing comprehensive exam questions) for graduate and professional courses in Pharmacotherapy, Nutrition, Critical Care, and Herbal and Natural Medicines
Summer Research Intern July 2013 – October 2013
Janssen Research and Development, Drug Metabolism and Pharmacokinetics Department
Project: Development and Optimization of Screening Assays for Drug-Drug Interactions
Supervisor: Dr. Carlo Sensenhauser
Designed and optimized novel screening assays for UDP-glucuronosyltransferase inhibition in human liver microsomes and recombinant enzymes used for drug-drug interaction studies
Assessed cytochrome p450 mechanism based inactivation in primary hepatocyte cell culture
Laboratory Technician October 2010 – May 2013
Clinical and Pharmacological Analytical Services
Project: The Effect of Cytochrome P450 2C9 Genetic Variation on Drug-Drug Interactions with Warfarin
Supervisor: James Fisher
Extracted and analyzed warfarin and its metabolites from plasma and urine using liquid-liquid extraction and high performance liquid chromatography-mass spectrometry
Performed general maintenance and repairs on high performance liquid chromatography-tandem mass spectrometers
Harrison Tam, PhD acvxoo@r.postjobfree.com
Work and Research Experience Continued
Research Assistant January 2008 – September 2010
University of Minnesota, College of Pharmacy
Project: Characterization of Cytochrome P450 Oxidoreductase and Cytochrome P450 2C9 variants
Supervisor: Dr. Timothy Tracy
Expressed and purified genetic variants of human cytochrome p450 enzymes for drug-drug interaction studies
Trained lab personnel on in-vitro utilization of cytochrome P450 enzymes
Collaborated with researchers at the University of California, San Francisco to study genetic variants in cytochrome P450 oxidoreductase and their effects on drug metabolism
Leadership Positions and Committees
Society of Postdoctoral Scholars Executive Committee September 2015- February 2016
University of Kentucky
Set up workshops on presentation skills/job searches/networking and social events for fellow post docs
Graduate Education Policy Committee September 2013- September 2014
University of Minnesota, College of Pharmacy
Created new policies for the structural reorganization of graduate teaching assistantships
Web Coordinator September 2012- September 2013
American Association of Pharmaceutical Scientists, University of Minnesota Chapter
Updated and maintained the chapter’s websites and set up workshops on presentation skills and job searches for fellow graduate students in related fields
Education
Doctorate of Philosophy in Experimental and Clinical Pharmacology January 2015 University of Minnesota, College of Pharmacy
Dissertation Title: The Effect of Obesity and High Fat Diet on Cardiovascular Risk and Intestinal Drug Metabolism
Bachelor’s of Science May 2008
University of Minnesota, College of Biological Sciences
Publications
Tam HK, Kelly AS, Fox CK, Nathan BM, Johnson LA. Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity.Child Obes. 2016 Mar 15. [Epub ahead of print]
Tam HK, Kelly AS, Metzig AM, Steinberger J, Johnson LA. Xanthine Oxidase and Cardiovascular Risk in Obese Children. Child Obes. 2014 Apr;10(2):175-80
Subramanian M, Agrawal V, Sandee D, Tam HK, Miller WL, Tracy TS. Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3. Pharmacogenet Genomics. 2012 Aug;22(8):590-7
Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM, Miller WL. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. Pharmacogenet Genomics. 2010 Nov;20(11):677-86
Subramanian M, Tam H, Zheng H, Tracy TS. CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminus. Drug Metab Dispos. 2010 Jun;38(6):1003-9.